CN105920669A - 一种复合细胞外基质成分生物材料 - Google Patents
一种复合细胞外基质成分生物材料 Download PDFInfo
- Publication number
- CN105920669A CN105920669A CN201610261472.1A CN201610261472A CN105920669A CN 105920669 A CN105920669 A CN 105920669A CN 201610261472 A CN201610261472 A CN 201610261472A CN 105920669 A CN105920669 A CN 105920669A
- Authority
- CN
- China
- Prior art keywords
- layer
- sis
- cell
- compound cells
- biogenic material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000004615 ingredient Substances 0.000 title claims abstract description 19
- 239000012620 biological material Substances 0.000 title claims abstract description 13
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 title abstract description 6
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 title abstract description 6
- 210000002744 extracellular matrix Anatomy 0.000 title abstract description 6
- 239000002131 composite material Substances 0.000 title abstract description 5
- 239000010410 layer Substances 0.000 claims abstract description 65
- 239000000463 material Substances 0.000 claims abstract description 64
- 210000003932 urinary bladder Anatomy 0.000 claims abstract description 12
- 210000004876 tela submucosa Anatomy 0.000 claims abstract description 5
- 210000000813 small intestine Anatomy 0.000 claims description 35
- 238000000034 method Methods 0.000 claims description 17
- 230000000035 biogenic effect Effects 0.000 claims description 14
- 210000002469 basement membrane Anatomy 0.000 claims description 8
- 230000008569 process Effects 0.000 claims description 8
- 239000011229 interlayer Substances 0.000 claims description 7
- 210000004400 mucous membrane Anatomy 0.000 claims description 6
- 210000003205 muscle Anatomy 0.000 claims description 6
- 102000008186 Collagen Human genes 0.000 claims description 5
- 108010035532 Collagen Proteins 0.000 claims description 5
- 239000000853 adhesive Substances 0.000 claims description 5
- 230000001070 adhesive effect Effects 0.000 claims description 5
- 241001465754 Metazoa Species 0.000 claims description 4
- 238000003475 lamination Methods 0.000 claims description 4
- 230000003387 muscular Effects 0.000 claims description 4
- 229920001661 Chitosan Polymers 0.000 claims description 3
- 210000004877 mucosa Anatomy 0.000 claims description 3
- 210000002826 placenta Anatomy 0.000 claims description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 2
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 claims description 2
- 229920001287 Chondroitin sulfate Polymers 0.000 claims description 2
- 108010080379 Fibrin Tissue Adhesive Proteins 0.000 claims description 2
- 108010010803 Gelatin Proteins 0.000 claims description 2
- 230000009471 action Effects 0.000 claims description 2
- 229940059329 chondroitin sulfate Drugs 0.000 claims description 2
- 239000008273 gelatin Substances 0.000 claims description 2
- 229920000159 gelatin Polymers 0.000 claims description 2
- 235000019322 gelatine Nutrition 0.000 claims description 2
- 235000011852 gelatine desserts Nutrition 0.000 claims description 2
- 229920002674 hyaluronan Polymers 0.000 claims description 2
- 229960003160 hyaluronic acid Drugs 0.000 claims description 2
- 239000000017 hydrogel Substances 0.000 claims description 2
- 229920001277 pectin Polymers 0.000 claims description 2
- 235000010987 pectin Nutrition 0.000 claims description 2
- 239000001814 pectin Substances 0.000 claims description 2
- 210000000481 breast Anatomy 0.000 claims 1
- -1 osseocolla Polymers 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 abstract description 33
- 230000007547 defect Effects 0.000 abstract description 8
- 230000005847 immunogenicity Effects 0.000 abstract description 7
- 230000008901 benefit Effects 0.000 abstract description 6
- 206010061218 Inflammation Diseases 0.000 abstract description 5
- 230000004054 inflammatory process Effects 0.000 abstract description 5
- 210000004872 soft tissue Anatomy 0.000 abstract description 5
- 239000002344 surface layer Substances 0.000 abstract description 4
- 230000000968 intestinal effect Effects 0.000 abstract description 3
- 210000002418 meninge Anatomy 0.000 abstract description 3
- 210000004224 pleura Anatomy 0.000 abstract description 3
- 238000002360 preparation method Methods 0.000 abstract description 3
- ULFUTCYGWMQVIO-PCVRPHSVSA-N [(6s,8r,9s,10r,13s,14s,17r)-17-acetyl-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1h-cyclopenta[a]phenanthren-17-yl] acetate;[(8r,9s,13s,14s,17s)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] pentano Chemical compound C1CC2=CC(O)=CC=C2[C@@H]2[C@@H]1[C@@H]1CC[C@H](OC(=O)CCCC)[C@@]1(C)CC2.C([C@@]12C)CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2CC[C@]2(C)[C@@](OC(C)=O)(C(C)=O)CC[C@H]21 ULFUTCYGWMQVIO-PCVRPHSVSA-N 0.000 abstract 1
- 210000004207 dermis Anatomy 0.000 abstract 1
- 210000003903 pelvic floor Anatomy 0.000 abstract 1
- 230000003014 reinforcing effect Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 19
- PTHLSIBOMNYSIS-UHFFFAOYSA-N 5-(4-aminophenyl)-8-chloro-3-methyl-1,2,4,5-tetrahydro-3-benzazepin-7-ol Chemical compound C1N(C)CCC2=CC(Cl)=C(O)C=C2C1C1=CC=C(N)C=C1 PTHLSIBOMNYSIS-UHFFFAOYSA-N 0.000 description 10
- 239000000047 product Substances 0.000 description 9
- 230000017423 tissue regeneration Effects 0.000 description 8
- 239000000203 mixture Substances 0.000 description 7
- 230000008439 repair process Effects 0.000 description 7
- 210000001691 amnion Anatomy 0.000 description 6
- 239000002158 endotoxin Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 230000033228 biological regulation Effects 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 231100000241 scar Toxicity 0.000 description 4
- 102000016359 Fibronectins Human genes 0.000 description 3
- 108010067306 Fibronectins Proteins 0.000 description 3
- 229920002683 Glycosaminoglycan Polymers 0.000 description 3
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 3
- 241000446313 Lamella Species 0.000 description 3
- 102000013275 Somatomedins Human genes 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 230000012292 cell migration Effects 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 210000001951 dura mater Anatomy 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 210000003195 fascia Anatomy 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 239000007943 implant Substances 0.000 description 3
- 238000002513 implantation Methods 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 2
- 102000002734 Collagen Type VI Human genes 0.000 description 2
- 108010043741 Collagen Type VI Proteins 0.000 description 2
- 206010018910 Haemolysis Diseases 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 102000016611 Proteoglycans Human genes 0.000 description 2
- 108010067787 Proteoglycans Proteins 0.000 description 2
- 206010040102 Seroma Diseases 0.000 description 2
- 101710172711 Structural protein Proteins 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 210000004177 elastic tissue Anatomy 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000008588 hemolysis Effects 0.000 description 2
- 239000000413 hydrolysate Substances 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 210000001139 rectus abdominis Anatomy 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 238000009418 renovation Methods 0.000 description 2
- 210000000130 stem cell Anatomy 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 230000037314 wound repair Effects 0.000 description 2
- 208000021970 Abdominal wall defect Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 102100036301 C-C chemokine receptor type 7 Human genes 0.000 description 1
- 108010009992 CD163 antigen Proteins 0.000 description 1
- 208000006313 Delayed Hypersensitivity Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102400001368 Epidermal growth factor Human genes 0.000 description 1
- 101800003838 Epidermal growth factor Proteins 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 1
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 1
- 102000003972 Fibroblast growth factor 7 Human genes 0.000 description 1
- 108090000385 Fibroblast growth factor 7 Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 101000716065 Homo sapiens C-C chemokine receptor type 7 Proteins 0.000 description 1
- 101000934372 Homo sapiens Macrosialin Proteins 0.000 description 1
- 208000008081 Intestinal Fistula Diseases 0.000 description 1
- 208000032420 Latent Infection Diseases 0.000 description 1
- 210000004322 M2 macrophage Anatomy 0.000 description 1
- 102100025136 Macrosialin Human genes 0.000 description 1
- 231100000678 Mycotoxin Toxicity 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 208000000450 Pelvic Pain Diseases 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 206010067268 Post procedural infection Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 102100025831 Scavenger receptor cysteine-rich type 1 protein M130 Human genes 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 208000031737 Tissue Adhesions Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 230000007541 cellular toxicity Effects 0.000 description 1
- 238000006757 chemical reactions by type Methods 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 208000037893 chronic inflammatory disorder Diseases 0.000 description 1
- 210000003690 classically activated macrophage Anatomy 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037771 disease arising from reactivation of latent virus Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229940116977 epidermal growth factor Drugs 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 210000000630 fibrocyte Anatomy 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000003118 histopathologic effect Effects 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 230000007688 immunotoxicity Effects 0.000 description 1
- 231100000386 immunotoxicity Toxicity 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000030214 innervation Effects 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 238000009940 knitting Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000010232 migration assay Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 239000002636 mycotoxin Substances 0.000 description 1
- POFWRMVFWIJXHP-UHFFFAOYSA-N n-benzyl-9-(oxan-2-yl)purin-6-amine Chemical compound C=1C=CC=CC=1CNC(C=1N=C2)=NC=NC=1N2C1CCCCO1 POFWRMVFWIJXHP-UHFFFAOYSA-N 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 210000004303 peritoneum Anatomy 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000000250 revascularization Effects 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 231100000161 signs of toxicity Toxicity 0.000 description 1
- 230000008470 skin growth Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3886—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells comprising two or more cell types
- A61L27/3891—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells comprising two or more cell types as distinct cell layers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3629—Intestinal tissue, e.g. small intestinal submucosa
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3633—Extracellular matrix [ECM]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
- A61L27/3691—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/40—Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Transplantation (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
Abstract
Description
Claims (10)
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610261472.1A CN105920669B (zh) | 2016-04-25 | 2016-04-25 | 一种复合细胞外基质成分生物材料 |
US16/095,633 US20190314553A1 (en) | 2016-04-25 | 2017-02-13 | A biological material with composite extracellular matrix components |
PCT/CN2017/073394 WO2017185853A1 (zh) | 2016-04-25 | 2017-02-13 | 一种复合细胞外基质成分生物材料 |
JP2019503607A JP6827522B2 (ja) | 2016-04-25 | 2017-02-13 | 複合細胞外マトリックス成分生体材料 |
EP17788509.2A EP3443990B1 (en) | 2016-04-25 | 2017-02-13 | Composite extracellular matrix biomaterial |
US17/518,124 US20220054707A1 (en) | 2016-04-25 | 2021-11-03 | Biological material with composite extracellular matrix components |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610261472.1A CN105920669B (zh) | 2016-04-25 | 2016-04-25 | 一种复合细胞外基质成分生物材料 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105920669A true CN105920669A (zh) | 2016-09-07 |
CN105920669B CN105920669B (zh) | 2019-03-29 |
Family
ID=56836273
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610261472.1A Active CN105920669B (zh) | 2016-04-25 | 2016-04-25 | 一种复合细胞外基质成分生物材料 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20190314553A1 (zh) |
EP (1) | EP3443990B1 (zh) |
JP (1) | JP6827522B2 (zh) |
CN (1) | CN105920669B (zh) |
WO (1) | WO2017185853A1 (zh) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107007886A (zh) * | 2017-03-03 | 2017-08-04 | 北京博辉瑞进生物科技有限公司 | 一种生物组织基质材料、制备方法及其用途 |
CN107080861A (zh) * | 2017-03-03 | 2017-08-22 | 北京博辉瑞进生物科技有限公司 | 一种高诱导活性的修复材料、制备方法和应用 |
WO2017185853A1 (zh) * | 2016-04-25 | 2017-11-02 | 上海卓阮医疗科技有限公司 | 一种复合细胞外基质成分生物材料 |
CN112999430A (zh) * | 2021-04-13 | 2021-06-22 | 健诺维(成都)生物科技有限公司 | 口腔修复膜及其制备方法 |
CN113908343A (zh) * | 2021-09-30 | 2022-01-11 | 卓阮医疗科技(苏州)有限公司 | 一种弯曲性能改良的生物材料 |
CN115025296A (zh) * | 2022-06-15 | 2022-09-09 | 上海新华瑞思医疗科技有限公司 | 一种引导组织再生的口腔修复膜及其制备方法和相关试剂盒 |
CN115444993A (zh) * | 2018-06-21 | 2022-12-09 | 联邦高等教育系统匹兹堡大学 | 细胞外基质(ecm)水凝胶作为食管粘膜下流体垫的用途 |
CN115970061A (zh) * | 2023-01-31 | 2023-04-18 | 上海卓阮医疗科技有限公司 | 用于缺乏血供场景的生物材料及其制备方法和应用 |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107349471A (zh) * | 2017-06-16 | 2017-11-17 | 卓阮医疗科技(苏州)有限公司 | 一种载药缓释的复合组织修复材料及其制备方法 |
CN114377210B (zh) * | 2020-10-19 | 2024-02-20 | 四川大学华西医院 | 一种聚氨酯/小肠粘膜下层/聚吡咯复合材料及其制备方法和用途 |
WO2022146730A1 (en) * | 2020-12-29 | 2022-07-07 | Acell, Inc. | Implantable pouch device and methods of making thereof |
WO2023211992A1 (en) * | 2022-04-27 | 2023-11-02 | Axogen Corporation | Sutureless connectors and methods of preparing and using same |
WO2024006421A1 (en) * | 2022-07-01 | 2024-01-04 | The Regents Of The University Of California | Method to direct vascularization of tissue grafts |
CN115814161A (zh) * | 2022-11-25 | 2023-03-21 | 深圳兰度生物材料有限公司 | 软组织修复材料及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101361989A (zh) * | 2008-09-03 | 2009-02-11 | 陕西瑞盛生物科技有限公司 | 双层膜状组织修补材料及其制备方法 |
CN101366979A (zh) * | 2008-09-03 | 2009-02-18 | 陕西瑞盛生物科技有限公司 | 一种组织补片及其制备方法 |
US20140309739A1 (en) * | 2009-02-27 | 2014-10-16 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Joint bioscaffolds |
CN105311679A (zh) * | 2015-11-24 | 2016-02-10 | 无锡中科光远生物材料有限公司 | 一种复合疝补片及其制备方法和应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6638312B2 (en) * | 2000-08-04 | 2003-10-28 | Depuy Orthopaedics, Inc. | Reinforced small intestinal submucosa (SIS) |
WO2009070686A1 (en) * | 2007-11-30 | 2009-06-04 | Cook Biotech Incorporated | Expandable plugs and related delivery apparatuses and methods |
CN102176929B (zh) * | 2008-07-01 | 2014-03-26 | 库克生物科技公司 | 包含浆膜下筋膜的分离的细胞外基质材料 |
US8298586B2 (en) * | 2009-07-22 | 2012-10-30 | Acell Inc | Variable density tissue graft composition |
CN105920669B (zh) * | 2016-04-25 | 2019-03-29 | 上海卓阮医疗科技有限公司 | 一种复合细胞外基质成分生物材料 |
-
2016
- 2016-04-25 CN CN201610261472.1A patent/CN105920669B/zh active Active
-
2017
- 2017-02-13 EP EP17788509.2A patent/EP3443990B1/en active Active
- 2017-02-13 WO PCT/CN2017/073394 patent/WO2017185853A1/zh active Application Filing
- 2017-02-13 JP JP2019503607A patent/JP6827522B2/ja active Active
- 2017-02-13 US US16/095,633 patent/US20190314553A1/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101361989A (zh) * | 2008-09-03 | 2009-02-11 | 陕西瑞盛生物科技有限公司 | 双层膜状组织修补材料及其制备方法 |
CN101366979A (zh) * | 2008-09-03 | 2009-02-18 | 陕西瑞盛生物科技有限公司 | 一种组织补片及其制备方法 |
US20140309739A1 (en) * | 2009-02-27 | 2014-10-16 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Joint bioscaffolds |
CN105311679A (zh) * | 2015-11-24 | 2016-02-10 | 无锡中科光远生物材料有限公司 | 一种复合疝补片及其制备方法和应用 |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017185853A1 (zh) * | 2016-04-25 | 2017-11-02 | 上海卓阮医疗科技有限公司 | 一种复合细胞外基质成分生物材料 |
CN107007886A (zh) * | 2017-03-03 | 2017-08-04 | 北京博辉瑞进生物科技有限公司 | 一种生物组织基质材料、制备方法及其用途 |
CN107080861A (zh) * | 2017-03-03 | 2017-08-22 | 北京博辉瑞进生物科技有限公司 | 一种高诱导活性的修复材料、制备方法和应用 |
CN107080861B (zh) * | 2017-03-03 | 2020-01-21 | 北京博辉瑞进生物科技有限公司 | 一种高诱导活性的修复材料、制备方法和应用 |
CN115444993A (zh) * | 2018-06-21 | 2022-12-09 | 联邦高等教育系统匹兹堡大学 | 细胞外基质(ecm)水凝胶作为食管粘膜下流体垫的用途 |
CN115444993B (zh) * | 2018-06-21 | 2024-03-29 | 联邦高等教育系统匹兹堡大学 | 细胞外基质(ecm)水凝胶作为食管粘膜下流体垫的用途 |
CN112999430A (zh) * | 2021-04-13 | 2021-06-22 | 健诺维(成都)生物科技有限公司 | 口腔修复膜及其制备方法 |
CN112999430B (zh) * | 2021-04-13 | 2022-06-17 | 健诺维(成都)生物科技有限公司 | 口腔修复膜及其制备方法 |
CN113908343A (zh) * | 2021-09-30 | 2022-01-11 | 卓阮医疗科技(苏州)有限公司 | 一种弯曲性能改良的生物材料 |
CN115025296A (zh) * | 2022-06-15 | 2022-09-09 | 上海新华瑞思医疗科技有限公司 | 一种引导组织再生的口腔修复膜及其制备方法和相关试剂盒 |
CN115025296B (zh) * | 2022-06-15 | 2024-06-11 | 上海新华瑞思医疗科技有限公司 | 一种引导组织再生的口腔修复膜及其制备方法和相关试剂盒 |
CN115970061A (zh) * | 2023-01-31 | 2023-04-18 | 上海卓阮医疗科技有限公司 | 用于缺乏血供场景的生物材料及其制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
EP3443990A4 (en) | 2019-05-08 |
JP6827522B2 (ja) | 2021-02-10 |
WO2017185853A1 (zh) | 2017-11-02 |
CN105920669B (zh) | 2019-03-29 |
EP3443990A1 (en) | 2019-02-20 |
US20190314553A1 (en) | 2019-10-17 |
EP3443990B1 (en) | 2020-09-30 |
JP2019513514A (ja) | 2019-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105920669A (zh) | 一种复合细胞外基质成分生物材料 | |
Badylak et al. | Macrophage phenotype as a determinant of biologic scaffold remodeling | |
RU2645473C2 (ru) | Тканевые конструкции, полученные с помощью биоинженерии, и способы их получения и применения | |
Abou Neel et al. | Collagen—emerging collagen based therapies hit the patient | |
JP5518066B2 (ja) | 前胃細胞外マトリックス由来の組織スキャフォールド | |
US20110293666A1 (en) | Bioengineered Tissue Constructs and Methods for Production and Use | |
CN101361990B (zh) | 一种双层人工皮肤及其制备方法 | |
Wang et al. | Polyurethane membrane/knitted mesh-reinforced collagen–chitosan bilayer dermal substitute for the repair of full-thickness skin defects via a two-step procedure | |
CN101366979B (zh) | 一种组织补片及其制备方法 | |
CN101147810B (zh) | 细胞-生物可降解材料复合物及其制备方法和应用 | |
CN107847460A (zh) | 减轻或改善大疱性表皮松解症用间叶干细胞‑水凝胶‑可降解性或间叶干细胞‑水凝胶‑不可降解性支持体组成物 | |
JP7168937B2 (ja) | 糸及びその製造方法 | |
CN105874060A (zh) | 间皮细胞在组织生物工程和人造组织中的用途 | |
CN104771787A (zh) | 一种含pga加强网的复合型支架、制备方法及应用 | |
US20220054707A1 (en) | Biological material with composite extracellular matrix components | |
KR101859654B1 (ko) | 각막 탈세포화 세포외 기질을 함유하는 각막 유래 세포의 지지체 및 이를 포함하는 인공 각막 시트 | |
Greenwood et al. | The use of biodegradable polyurethane in the development of dermal scaffolds | |
CN105169494A (zh) | 一种组织工程皮肤的制备方法 | |
Al-Bayati et al. | Role of acellular bovine urinary bladder submucosa on skin wound healing in Iraqi goats | |
US20130123938A1 (en) | Stitchable tissue transplant construct for the reconstruction of a human or animal organ | |
Mohsina et al. | Bioengineered acellular dermal matrices for the repair of abdominal wall defects in rats | |
RU2736480C2 (ru) | Способ производства коллаген-ламининового матрикса для заживления язв, ожогов и ран кожи человека | |
WO2021152322A1 (en) | Novel corneal tissues and methods of making the same | |
CN210698333U (zh) | 一种软组织生物修补网片 | |
Guide | Dedicated to.... My |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20160907 Assignee: ZHUORUAN MEDICAL TECHNOLOGY (SUZHOU) Co.,Ltd. Assignor: SHANGHAI EXCELLENCE MEDICAL TECHNOLOGIES Co.,Ltd. Contract record no.: 2017310000060 Denomination of invention: Composite extracellular matrix ingredient biological material License type: Common License Record date: 20171106 |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240206 Address after: 215400 No. 52 Yingang Road, Taicang Port Economic and Technological Development Zone, Suzhou City, Jiangsu Province Patentee after: ZHUORUAN MEDICAL TECHNOLOGY (SUZHOU) Co.,Ltd. Country or region after: China Patentee after: SHANGHAI EXCELLENCE MEDICAL TECHNOLOGIES Co.,Ltd. Address before: Room 101-1, Building 4, No. 333, Guiping Road, Xuhui District, Shanghai, 200233 Patentee before: SHANGHAI EXCELLENCE MEDICAL TECHNOLOGIES Co.,Ltd. Country or region before: China |